Literature DB >> 19900192

Critical roles of T-LAK cell-originated protein kinase in cytokinesis.

Jae-Hyun Park1, Toshihiko Nishidate, Yusuke Nakamura, Toyomasa Katagiri.   

Abstract

We previously reported up-regulation of T-LAK cell-originated protein kinase (TOPK), a novel mitotic kinase, in the great majority of breast cancers. Here we report its critical roles in mitosis, especially in cytokinesis. We found that protein phosphatase 1 alpha (PP1alpha) inactivation by cyclin-dependent kinase 1 (CDK1)/cyclin B1 caused enhancement of autophosphorylation of TOPK and resulted in its activation at an early stage of mitosis. Then TOPK interacted with and phosphorylated p97, a member of the AAA+ family of ATPase proteins, through an interaction with p47 protein as an adaptor protein. Interestingly, knockdown of TOPK or p97 in breast cancer cells caused the mitotic failures in the abscission process. This mitotic failure could be rescued by additional exogenous introduction of wild-type TOPK protein, but not by that of its kinase-dead form. Our findings suggest that TOPK is indispensable for cancer cell cytokinesis throughout phosphorylation on p97.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19900192     DOI: 10.1111/j.1349-7006.2009.01400.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  36 in total

1.  Liposomal OTS964, a TOPK inhibitor: a simple method to estimate OTS964 association with liposomes that relies on enhanced OTS964 fluorescence when bound to albumin.

Authors:  Roger Gilabert-Oriol; Brent W Sutherland; Malathi Anantha; Alessia Pallaoro; Marcel B Bally
Journal:  Drug Deliv Transl Res       Date:  2019-12       Impact factor: 4.617

2.  CDK1-mediated mitotic phosphorylation of PBK is involved in cytokinesis and inhibits its oncogenic activity.

Authors:  Seth Stauffer; Yongji Zeng; Jiuli Zhou; Xingcheng Chen; Yuanhong Chen; Jixin Dong
Journal:  Cell Signal       Date:  2017-08-03       Impact factor: 4.315

3.  Targeting PDZ-binding kinase is anti-tumorigenic in novel preclinical models of ACC.

Authors:  Adwitiya Kar; Yu Zhang; Betelehem W Yacob; Jordan Saeed; Kenneth D Tompkins; Stacey M Bagby; Todd M Pitts; Hilary Somerset; Stephen Leong; Margaret E Wierman; Katja Kiseljak-Vassiliades
Journal:  Endocr Relat Cancer       Date:  2019-10       Impact factor: 5.678

4.  ADA-07 Suppresses Solar Ultraviolet-Induced Skin Carcinogenesis by Directly Inhibiting TOPK.

Authors:  Ge Gao; Tianshun Zhang; Qiushi Wang; Kanamata Reddy; Hanyong Chen; Ke Yao; Keke Wang; Eunmiri Roh; Tatyana Zykova; Weiya Ma; Joohyun Ryu; Clara Curiel-Lewandrowski; David Alberts; Sally E Dickinson; Ann M Bode; Ying Xing; Zigang Dong
Journal:  Mol Cancer Ther       Date:  2017-06-27       Impact factor: 6.261

5.  TOPKi-NBD: a fluorescent small molecule for tumor imaging.

Authors:  Giacomo Pirovano; Sheryl Roberts; Thomas Reiner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-16       Impact factor: 9.236

6.  The design of TOPK inhibitors using structure-based pharmacophore modeling and molecular docking based on an MD-refined homology model.

Authors:  Lara I Fakhouri; Nizar A Al-Shar'i
Journal:  Mol Divers       Date:  2022-01-15       Impact factor: 3.364

7.  [18F]FE-OTS964: a Small Molecule Targeting TOPK for In Vivo PET Imaging in a Glioblastoma Xenograft Model.

Authors:  Giacomo Pirovano; Sheryl Roberts; Christian Brand; Patrick L Donabedian; Christian Mason; Paula Demétrio de Souza; Geoff S Higgins; Thomas Reiner
Journal:  Mol Imaging Biol       Date:  2019-08       Impact factor: 3.488

Review 8.  Development of small molecular compounds targeting cancer stem cells.

Authors:  Jae-Hyun Park; Suyoun Chung; Yo Matsuo; Yusuke Nakamura
Journal:  Medchemcomm       Date:  2016-11-11       Impact factor: 3.597

Review 9.  PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential.

Authors:  Hai Huang; Mee-Hyun Lee; Kangdong Liu; Zigang Dong; Zeayoung Ryoo; Myoung Ok Kim
Journal:  Cancers (Basel)       Date:  2021-05-06       Impact factor: 6.639

10.  Sharp Downregulation of Hub Genes Associated With the Pathogenesis of Breast Cancer From Ductal Carcinoma In Situ to Invasive Ductal Carcinoma.

Authors:  Yao Wang; Faqing Liang; Yuting Zhou; Juanjuan Qiu; Qing Lv; Zhenggui Du
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.